Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists
Singh, Brahma N; Prateeksha; Upreti, Dalip K; Singh, Braj Raj; Defoirdt, Tom; Gupta, Vijai K; de Souza, Ana Olívia; Singh, Harikesh Bahadur; Barreira, Joao C. M; Ferreira, Isabel C. F. R; Vahabi, Khabat.
Crit. Rev. Biotechnol.
; 37(4): 525-540, 2017.
Artículo
en Inglés
| SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib15173
Despite several conventional potent antibacterial therapies, bacterial infections pose a significant threat to human health because they are emerging as the leading cause of death worldwide. Due to the development of antibiotic resistance in bacteria, there is a pressing demand to discover novel approaches for developing more effective therapies to treat multidrug-resistant bacterial strains and biofilm-associated infections. Therefore, attention has been especially devoted to a new and emerging branch of science "nanotechnology" to design non-conventional antimicrobial chemotherapies. A range of nanomaterials and nano-sized carriers for conventional antimicrobial agents have fully justified their potential to combat bacterial diseases by reducing cell viability, by attenuating quorum sensing, and by inhibiting/or eradicating biofilms. This communication summarizes emerging nano-antimicrobial therapies in treating bacterial infections, particularly using antibacterial, quorum quenching, and anti-biofilm nanomaterials as new approaches to tackle the current challenges in combating infectious diseases.
Biblioteca responsable:
BR78.1
Ubicación: BR78.1
Texto completo
Documentos relacionados